Aurinia Pharmaceuticals to Discuss Phase 1 AUR200 Study Results – Webcast Details
Date: June 30, 2025
Time: 8:30 a.m. ET
Event: Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) will host a webcast and conference call to discuss results from the AUR200 Phase 1 study.
Webcast Link: [https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fcan01.safelinks.protection.outlook.com%2F%3Furl%3Dhttps%253A%252F%252Fevent.choruscall.com%252Fmediaframe%252Fwebcast.html%253Fwebcastid%253DE7aNqqNL%26data%3D05%257C02%257CRMeister%2540auriniapharma.com%257Ca3fcab3d205a43d8d2d608ddb58d45a2%257C2ae9339148124f01bdb23fc941209611%257C0%257C0%257C638866340547798692%257CUnknown%257CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%253D%253D%257C0%257C%257C%257C%26sdata%3DVTZWNYdT6G4sLBsLmtVqZdA3zWavMWBLK07RVlKlzB4%253D%26reserved
